SWOT Analysis for Ipca Laboratories Ltd. - Strengths

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years - Nifty500

Company with high TTM EPS Growth

Expensive Performers (DVM)

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Companies with rising net profit margins - quarterly as well as TTM basis

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Company with Low Debt

Increasing profits every quarter for the past 3 quarters

Book Value per share Improving for last 2 years

Company with Zero Promoter Pledge

Stocks in uptrend most likely to cross above SMA-200 soon

Top Gainers

Volume Shockers

Promoter decreasing their shareholding

Companies with growing costs YoY for long term projects

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Declining Net Cash Flow : Companies not able to generate net cash

Stocks Underperforming their Industry Price Change in the Quarter

Brokers upgraded recommendation or target price in the past three months

Mutual Funds Increased Shareholding in Past Month

Street Favorite: High Analyst Rating with at least 20% upside

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Rising Delivery Percentage Compared to Prev Day

Indian stocks that could be impacted by Brexit (Britain leaving the EU)

Expensive Performers (DVM)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks